Modifications of cysteine-rich regions in protein kinase C induced by oxidant tumor promoters and enzyme-specific inhibitors.
D000470:Alkaloids / Q000494:pharmacology; D000477:Alkylating Agents; D000873:Anthracenes; D053119:Benzophenanthridines; D001665:Binding Sites / Q000187:drug effects; D002273:Carcinogens / Q000494:pharmacology*; D003545:Cysteine / Q000187:drug effects; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006861:Hydrogen Peroxide / Q000494:pharmacology; D007527:Isoenzymes / Q000037:antagonists & inhibitors / Q000187:drug effects*; D007546:Isoquinolines; D009281:Naphthalenes / Q000494:pharmacology; D009569:Nitric Oxide / Q000494:pharmacology; D016877:Oxidants / Q000494:pharmacology*; D010504:Periodic Acid; D010569:Perylene / Q000031:analogs & derivatives / Q000494:pharmacology; D010617:Phenanthridines / Q000494:pharmacology; D010703:Phorbol Esters / Q000378:metabolism; D010770:Phosphotransferases; D011493:Protein Kinase C / Q000037:antagonists & inhibitors / Q000187:drug effects*
D000470:Alkaloids; D000477:Alkylating Agents; D000873:Anthracenes; D053119:Benzophenanthridines; D002273:Carcinogens; D004791:Enzyme Inhibitors; D007527:Isoenzymes; D007546:Isoquinolines; D009281:Naphthalenes; D016877:Oxidants; D010617:Phenanthridines; D010703:Phorbol Esters; D010504:Periodic Acid; D009569:Nitric Oxide; D010569:Perylene; C004965:hypericin; C005705:sanguinarine; C009288:metaperiodate; D006861:Hydrogen Peroxide; C016299:chelerythrine; D010770:Phosphotransferases; D011493:Protein Kinase C; C058819:calphostin C; D003545:Cysteine